UK cost agency backs Medivation, Astellas prostate cancer pill
LONDON (Reuters) - Britain's healthcare cost watchdog NICE has recommended that a new prostate cancer pill from Medivation and Astellas should be used...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/j-b05dnyVqk/story01.htm
No comments:
Post a Comment